Profil
Edward A Hjerpe is currently the Director at Tergus Pharma LLC and the Senior Associate at Great Point Partners Private Equity.
Previously, he worked as a Principal at Sandler O'Neill & Partners LP.
He completed his undergraduate and graduate degrees at the University of Notre Dame.
Postes actifs de Edward A Hjerpe
| Sociétés | Poste | Début |
|---|---|---|
Great Point Partners Private Equity
Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Analyste en capital-investissement | - |
Tergus Pharma LLC
Tergus Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical research, drug development, testing and manufacturing company | Directeur/Membre du Conseil | - |
Anciens postes connus de Edward A Hjerpe
| Sociétés | Poste | Fin |
|---|---|---|
Sandler O'Neill & Partners LP
Sandler O'Neill & Partners LP Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Formation de Edward A Hjerpe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandler O'Neill & Partners LP
Sandler O'Neill & Partners LP Investment Banks/BrokersFinance Provides brokerage services | Finance |
Great Point Partners Private Equity
Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Finance |
Tergus Pharma LLC
Tergus Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical research, drug development, testing and manufacturing company | Health Technology |
















